21 CFR 522.2150
§ 522.2150 Stanozolol.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.2150, § 522.2150 Stanozolol, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87536
- Permanent ID
ys:prov:87536@1- SHA-256
aad6d4f36070057bbdd570ba5d39e82f21993a27c31b79906d3002a97a26b183
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of suspension contains 50 milligrams (mg) of stanozolol.
(b) Sponsor. No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amount—(i) Dogs and cats. For cats and small breeds of dogs: 25 mg. For larger dogs: 50 mg. Administer by deep intramuscular injection in the thigh at weekly intervals, for several weeks.
(ii) Horses. Administer 25 mg per 100 pounds of body weight by deep intramuscular injection in the gluteal region at weekly intervals, for not more than 4 weeks.
(2) Indications for use. For use as an anabolic steroid treatment.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.